Dupilumab in prurigo nodularis
52-Week effectiveness and safety from the prospective multicenter BioDay registry.
van der Gang LF, Bacoş-Cosma O, de Graaf M, Simon L, Loman L, Harbers VEM, van der Poel LAJ, Stadhouders-Keet SAE, van Lynden-van Nes AMT, van Erp FC, Lam HY, Zuithoff NPA, Haeck IM, Schuttelaar MA, de Bruin-Weller MS
Journal of the American Academy of DermatologyIn the feed 18 Jul 2026, published online 18 Jul 2026, issue 2026 Jul 18, added to PubMed 18 Jul 2026
Topics: Itch & prurigoBiologics
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42471138 · DOI 10.1016/j.jaad.2026.07.046